Pharmacological treatment of COVID-19: an opinion paper
A García-Lledó, J Gómez-Pavón… - Revista Española …, 2021 - pmc.ncbi.nlm.nih.gov
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …
most significant and saving advance against the pandemic. The development of vaccines …
Nanomaterials for photocatalytic degradations of analgesic, mucolytic and anti-biotic/viral/inflammatory drugs widely used in controlling SARS-CoV-2
M Ebrahimi, O Akhavan - Catalysts, 2022 - mdpi.com
The COVID-19 pandemic has been transformed into one of the main worldwide challenges,
in recent years. For controlling symptoms that are caused by this disease (eg, chills or fever …
in recent years. For controlling symptoms that are caused by this disease (eg, chills or fever …
[HTML][HTML] Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
JD Chalmers, ML Crichton… - European respiratory …, 2021 - Eur Respiratory Soc
Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …
Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database
The development of safe, effective, affordable vaccines against COVID-19 remains the
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups …
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups …
HIV and COVID-19: review of clinical course and outcomes
LK Barbera, KF Kamis, SE Rowan… - HIV research & …, 2021 - Taylor & Francis
Background: Understanding the relationship between HIV and SARS-CoV-2 has important
public health implications. Objective: To summarize current research on COVID-19 among …
public health implications. Objective: To summarize current research on COVID-19 among …
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
N Roche, ML Crichton, PC Goeminne… - European respiratory …, 2022 - Eur Respiratory Soc
Since the identification of SARS-CoV-2 at the end of 2019, the coronavirus disease 2019
(COVID-19) pandemic has affected more than 410 million people worldwide and killed …
(COVID-19) pandemic has affected more than 410 million people worldwide and killed …
[PDF][PDF] Retracted: meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
A Hill, A Garratt, J Levi, J Falconer, L Ellis… - Open Forum …, 2021 - academic.oup.com
Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …
Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia
S Alhumaid, A Al Mutair, Z Al Alawi, K Al Salman… - European Journal of …, 2021 - Springer
Background COVID-19 is a worldwide pandemic and has placed significant demand for
acute and critical care services on hospitals in many countries. Objectives To determine the …
acute and critical care services on hospitals in many countries. Objectives To determine the …
Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: A meta-analysis
Aim: To evaluate the efficacy and safety of lopinavir–ritonavir (LPV/r) therapy in treating
hospitalized COVID-19 patients. Materials & methods: Data from randomized and …
hospitalized COVID-19 patients. Materials & methods: Data from randomized and …
Use of antivirals in SARS-CoV-2 infection. Critical review of the role of remdesivir
The aim of this report is to review the literature and shed light on the uncertainties
surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This …
surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This …